TransCode Therapeutics Announces First Patients Treated in Phase 1 Clinical Trial with First-in-Class Lead Therapeutic Candidate
Biospace,
Two patients dosed; several additional patients screened for enrollment Trial to evaluate safety and tolerability of TTX-MC138…